ORIC Pharmaceuticals Inc. · 1 day ago
Senior Director/Director Business Development (oncology)
ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients’ lives by overcoming resistance in cancer. The Director/Senior Director, Business Development, is a strategic leader responsible for driving growth, forging key partnerships, and advancing the company’s oncology pipeline.
BiopharmaBiotechnologyHealth CarePharmaceuticalTherapeutics
Responsibilities
Develop and maintain a comprehensive understanding of the company’s oncology pipeline, R&D capabilities, and strategic objectives
Lead competitive intelligence and therapeutic area landscape assessments in prostate cancer and non-small cell lung cancer, providing actionable insights to cross-functional stakeholders
Build and manage strategic alliances with current and prospective partners in the oncology space, ensuring alignment with corporate goals
Stay abreast of industry trends and competitor activities in oncology to inform business development strategy
Support executive leadership in strategic planning, forecasting, and the development of presentation materials for internal and external audiences
Identify, evaluate, and recommend new business development opportunities, including in-licensing, out-licensing, partnerships, and M&A, with a focus on oncology assets
Oversee due diligence processes, including scientific, clinical, market, and financial analyses to support business cases for new oncology opportunities
Qualification
Required
Bachelor's degree in life sciences required
8–10+ years of biotechnology or pharmaceutical industry experience, with a proven track record in oncology business development, competitive intelligence, market research, and/or strategic partnerships
Excellent communication, presentation, and relationship-building abilities
Strong analytical, financial modeling, and project management skills
Commercial, clinical and scientific acumen in oncology
Strategic thinking and problem-solving in oncology drug development
Influencing and negotiation with scientific, clinical and commercial partners
Cross-functional collaboration (R&D, clinical, regulatory, commercial)
Deep understanding of oncology therapeutic landscapes
Experience with interpreting scientific data, analyzing clinical trial designs, understanding regulatory frameworks, and evaluating commercial opportunities for oncology therapies
Ability to assess and communicate the value proposition of oncology programs to internal and external stakeholders
Preferred
advanced degree (MBA, MS, MD, or PhD)
Company
ORIC Pharmaceuticals Inc.
ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer.
Funding
Current Stage
Public CompanyTotal Funding
$533MKey Investors
SR OneNextech InvestPfizer
2025-05-28Post Ipo Equity· $125M
2024-01-30Post Ipo Equity· $125M
2023-06-26Post Ipo Equity· $85M
Recent News
2025-12-24
2025-12-18
2025-12-18
Company data provided by crunchbase